Sign In
Buy ALDX
$1.54
-0.0600 (-3.75%)
At Close: Jul 31, 2026
These Mass. companies are developing COVID-19 treatments and tests
10:35am, Thursday, 16'th Apr 2020Company News for Apr 15, 2020
01:47pm, Wednesday, 15'th Apr 2020
Companies in the news are: WFC, FAST, FRC, ALDX
78 Biggest Movers From Yesterday
08:45am, Wednesday, 15'th Apr 2020
Gainers
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 61.7% to close at $7.99 on Tuesday.
NeuroMetrix, Inc. (NASDAQ: NURO) shares gained 58.7% to close at $...
Mid-Afternoon Market Update: NASDAQ Surges 4%; NeuroBo Pharmaceuticals Shares Plunge
06:35pm, Tuesday, 14'th Apr 2020
Toward the end of trading Tuesday, the Dow traded up 2.43% to 23959.78 while the NASDAQ rose 4% to 8,519.79. The S&P also rose, gaining 2.98% to 2843.81.
The U.S. is the...
55 Stocks Moving In Tuesday's Mid-Day Session
04:52pm, Tuesday, 14'th Apr 2020
Gainers
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares jumped 179% to $13.77.
NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 47.6% to $2.79 after surging over 42% on...
Mid-Day Market Update: Crude Oil Down 5.5%; New Age Beverages Shares Jump
04:18pm, Tuesday, 14'th Apr 2020
Midway through trading Tuesday, the Dow traded up 1.82% to 23816.13 while the NASDAQ rose 2.98% to 8,436.29. The S&P also rose, gaining 2.21% to 2,822.76.
The U.S. is the...
Mid-Morning Market Update: Markets Open Higher; JPMorgan Posts Lower Q1 Profit
02:24pm, Tuesday, 14'th Apr 2020
Following the market opening Tuesday, the Dow traded up 2.7% to 24021.69 while the NASDAQ rose 3.43% to 8,473.43. The S&P also rose, gaining 2.87% to 2,840.94.
The U.S. is the...
ROKU, CCL among premarket gainers today
01:20pm, Tuesday, 14'th Apr 2020
Sonnet BioTherapeutics Holdings (NASDAQ:SONN) +100%.MEI Pharma (NASDAQ:MEIP) +71% on license deal for blood cancer candidate.NantKwest (NASDAQ:NK) +39% being with ImmunityBio on active discussion
Aldeyra Announces Positive Top-Line Phase 1 Clinical Trial Results and Clinical Development Plans for ADX-629
12:00pm, Tuesday, 14'th Apr 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immun
Aldeyra Announces Top-Line Phase 1 Clinical Trial Results And Clinical Development Plans For ADX-629
12:00am, Tuesday, 14'th Apr 2020Edited Transcript of ALDX earnings conference call or presentation 12-Mar-20 12:00pm GMT
05:42am, Wednesday, 01'st Apr 2020
Q4 2019 Aldeyra Therapeutics Inc Earnings Call
Pharma, Biotech Players Step Up Efforts Against Coronavirus
12:50pm, Friday, 27'th Mar 2020
Several pharma & biotech companies announce their plan to fight coronavirus pandemic and state anticipated unfavorable impact of the outbreak on their business.
Aldeyra to Screen Clinical-Stage Compounds for Activity in COVID-19 Infection
12:00pm, Tuesday, 24'th Mar 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that it will begin screening its library of novel reactive aldehyde species (RASP) inhibitors, including ADX-629 and reproxalap, for
Analysts' Top Healthcare Picks: Xeris Pharmaceuticals (XERS), Verastem (VSTM)
01:13pm, Friday, 20'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xeris Pharmaceuticals (XERS) and Verastem (VSTM) with
